
Avadel Pharmaceuticals PLC
NASDAQ:AVDL

Avadel Pharmaceuticals PLC?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
7.49
18.82
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Avadel Pharmaceuticals PLC hold over its rivals?
What risks and challenges
does Avadel Pharmaceuticals PLC face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Avadel Pharmaceuticals PLC.
Provide an overview of the primary business activities
of Avadel Pharmaceuticals PLC.
What unique competitive advantages
does Avadel Pharmaceuticals PLC hold over its rivals?
What risks and challenges
does Avadel Pharmaceuticals PLC face in the near future?
Has there been any significant insider trading activity
in Avadel Pharmaceuticals PLC recently?
Summarize the latest earnings call
of Avadel Pharmaceuticals PLC.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Avadel Pharmaceuticals PLC.
Provide P/S
for Avadel Pharmaceuticals PLC.
Provide P/E
for Avadel Pharmaceuticals PLC.
Provide P/OCF
for Avadel Pharmaceuticals PLC.
Provide P/FCFE
for Avadel Pharmaceuticals PLC.
Provide P/B
for Avadel Pharmaceuticals PLC.
Provide EV/S
for Avadel Pharmaceuticals PLC.
Provide EV/GP
for Avadel Pharmaceuticals PLC.
Provide EV/EBITDA
for Avadel Pharmaceuticals PLC.
Provide EV/EBIT
for Avadel Pharmaceuticals PLC.
Provide EV/OCF
for Avadel Pharmaceuticals PLC.
Provide EV/FCFF
for Avadel Pharmaceuticals PLC.
Provide EV/IC
for Avadel Pharmaceuticals PLC.
Show me price targets
for Avadel Pharmaceuticals PLC made by professional analysts.
What are the Revenue projections
for Avadel Pharmaceuticals PLC?
How accurate were the past Revenue estimates
for Avadel Pharmaceuticals PLC?
What are the Net Income projections
for Avadel Pharmaceuticals PLC?
How accurate were the past Net Income estimates
for Avadel Pharmaceuticals PLC?
What are the EPS projections
for Avadel Pharmaceuticals PLC?
How accurate were the past EPS estimates
for Avadel Pharmaceuticals PLC?
What are the EBIT projections
for Avadel Pharmaceuticals PLC?
How accurate were the past EBIT estimates
for Avadel Pharmaceuticals PLC?
Compare the revenue forecasts
for Avadel Pharmaceuticals PLC with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Avadel Pharmaceuticals PLC and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Avadel Pharmaceuticals PLC against its competitors.
Analyze the profit margins
(gross, operating, and net) of Avadel Pharmaceuticals PLC compared to its peers.
Compare the P/E ratios
of Avadel Pharmaceuticals PLC against its peers.
Discuss the investment returns and shareholder value creation
comparing Avadel Pharmaceuticals PLC with its peers.
Analyze the financial leverage
of Avadel Pharmaceuticals PLC compared to its main competitors.
Show all profitability ratios
for Avadel Pharmaceuticals PLC.
Provide ROE
for Avadel Pharmaceuticals PLC.
Provide ROA
for Avadel Pharmaceuticals PLC.
Provide ROIC
for Avadel Pharmaceuticals PLC.
Provide ROCE
for Avadel Pharmaceuticals PLC.
Provide Gross Margin
for Avadel Pharmaceuticals PLC.
Provide Operating Margin
for Avadel Pharmaceuticals PLC.
Provide Net Margin
for Avadel Pharmaceuticals PLC.
Provide FCF Margin
for Avadel Pharmaceuticals PLC.
Show all solvency ratios
for Avadel Pharmaceuticals PLC.
Provide D/E Ratio
for Avadel Pharmaceuticals PLC.
Provide D/A Ratio
for Avadel Pharmaceuticals PLC.
Provide Interest Coverage Ratio
for Avadel Pharmaceuticals PLC.
Provide Altman Z-Score Ratio
for Avadel Pharmaceuticals PLC.
Provide Quick Ratio
for Avadel Pharmaceuticals PLC.
Provide Current Ratio
for Avadel Pharmaceuticals PLC.
Provide Cash Ratio
for Avadel Pharmaceuticals PLC.
What is the historical Revenue growth
over the last 5 years for Avadel Pharmaceuticals PLC?
What is the historical Net Income growth
over the last 5 years for Avadel Pharmaceuticals PLC?
What is the current Free Cash Flow
of Avadel Pharmaceuticals PLC?
Discuss the annual earnings per share (EPS)
trend over the past five years for Avadel Pharmaceuticals PLC.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
IE |
![]() |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
724.9m USD | 4.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
763B USD | 16.9 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.9B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 7.3 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
233.1B CHF | 4 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
176.2B GBP | 4.2 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.3B CHF | 4.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
220.6B USD | 3.4 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 72.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
139B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
IE |
![]() |
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Average P/S:
63.8
4.3
|
34%
|
0.1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
16.9
|
22%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
3%
|
1.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
7.3
|
17%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
4
|
5%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.2
|
7%
|
0.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.4
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
72.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
0%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.